Currently working in the field of regenerative medicine, with a primary focus on stem cell–based therapies and platelet-rich plasma (PRP)–based regenerative approaches for androgenetic alopecia (AGA), skin rejuvenation, tissue repair, and musculoskeletal and joint-related conditions. My research focuses on the therapeutic potential of adipose-derived stem cells (ADSCs), peripheral blood-derived stem cells (PBSCs), and stem cell–derived secretomes and extracellular vesicles (exosomes), with particular interest in their roles in hair follicle regeneration, skin repair, angiogenesis, tissue regeneration, oxidative stress, and inflammation modulation. Through translational and clinically oriented research, I aim to contribute to the development and advancement of safe, evidence-based regenerative therapies for hair restoration, skin health, tissue repair, and joint-related disorders.
Our research investigates the molecular and physiological mechanisms connecting the brain and cardiovascular system, focusing on how neurotransmitters, NMDA receptor signaling, neuropeptides, and oxidative stress influence cardiovascular regulation and disease. Integrating Cardiovascular Pharmacology, Neuropharmacology, and Neurophysiology, We explore how NMDA receptor activity modulates neuronal excitability and autonomic control, shaping blood pressure and heart function.
We particularly interested in how neuropeptides interact with NMDA receptor pathways within central regions such as the PVN, RVLM, CVLM, and NTS, which coordinate sympathetic output and circulatory homeostasis. Imbalances in excitatory and inhibitory inputs or oxidative stress in these regions lead to sympathetic overactivation and neurogenic hypertension.
In parallel, We examine ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, as a shared mechanism of neurodegeneration and cardiovascular dysfunction. Through this integrated approach, my work aims to elucidate the neurochemical and redox mechanisms underlying brain–heart communication, ultimately contributing to improved therapeutic strategies for hypertension, heart disease, and neurodegenerative disorders.
The role of tau protein and pharmacological modulation of NMDA receptor